BCL2 and diffuse large B-cell lymphoma: Similar to mouse VavP-Bcl2+Aicda lymphomas, we found that AICDA-high DLBCL patients manifested greater global inter-tumor heterogeneity than AICDA-low cases (Fig. 4a; Wilcoxon's P = 4.17e−06).